首页> 外文会议>Gastrointestinal Cancers Symposium >Screening for Colorectal Cancer: Which Tool and How Often?
【24h】

Screening for Colorectal Cancer: Which Tool and How Often?

机译:筛选结直肠癌:哪种工具和频率?

获取原文
获取外文期刊封面目录资料

摘要

In 2008 two U.S. groups updated their guidelines for colorectal cancer (CRC) screening, based on a review of the existing evidence. The U.S. Multi-Society Task Force (USMSTF) defines two categories of screening test. In the first category are tests that primarily detect cancers. Tests that are recommended in this category for screening average risk persons (50 years and older, no symptoms, no family history of the disease) are: annual high-sensitivity guaiac fecal occult blood test (gFOBT), annual fecal immunochemical test (FIT), or stool DNA (interval uncertain). In the second category are tests that detect both cancers and adenomas. Recommended tests in this category for screening persons at average risk are: flexible sigmoidoscopy (FS) every 5 years, colonoscopy every 10 years, double-contrast barium enema every 5 years, or CT colonography every 5 years.
机译:在2008年,两组根据对现有证据的审查,更新了他们的结肠直肠癌(CRC)筛查指南。美国多社会任务队(USMSTF)定义了两类筛选试验。在第一类中,是主要检测癌症的测试。在此类别中推荐的测试,用于筛选平均风险人员(50岁及以上,无症状,无疾病的家族史)是:年度高敏感性Guaiac粪便血液检测(GFOBT),年粪免疫化学测试(适合) ,或粪便DNA(间隔不确定)。在第二类中,是检测癌症和腺瘤的测试。该类别的推荐测试用于平均风险的筛选人员是:柔性Sigmoidoce(FS)每5年一次,每10年结肠镜检查每5年一次,每5年一次,每5年一次CT结肠灌肠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号